Smith Asset Management Group »

Amicus Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2012-09-30 $7.8M 1.8k 4415.00
2012-06-30 $624M 113k 5500.00
2012-03-31 $615M 117k 5280.00

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
BlackRock
Jpmorgan Chase & Co
Wellington Management Company
Henderson Group
Redmile Group
William Blair Investment Management
Morgan Stanley
Palo Alto Investors
Pictet Asset Management Holding SA
Geode Capital Management
Fiera Capital Corporation
American Century Companies

View all funds holding Amicus Therapeutics